Lady-Comp Fertility Monitor

Lady-Comp Fertility Monitor - Fahrenheit

“Smart” is that the ladycomp fertility monitor was nicknamed by its manufacturer, because it has been able to give accurate results when a woman is fertile or not. If you wish to avoid pregnancy or want to get pregnant quickly, so it is important to know when you are Ovulating. Equipped with technology that is able to analyze and track your menstrual cycle, ladycomp fertility monitor alerts you when the best time for that to refrain from sex to avoid pregnancy, or when you have more than what he is capable of conceiving. He said having an accuracy of 99.3%, which means that the error window is relatively small, that this device is very reliable. This device provides accurate results within a minute after use. It is completely safe to use because it does not require that any drug which means that they do not suffer side effects. Compared to the timetable of graphics and ovulation, fertility monitor Lady comp is easier to use and because it is automatic, gives more accurate results. It comes in degrees Celsius or Fahrenheit models and digital is easier to read and does not need any test messed up sticks or charges of any kind. A free personal to help him start cycle chart is free to buy one.



Eco World Content From Across The Internet.

EcoPressed
Featured on EcoPressed


Google reveals electricity use, aims for a third clean power by 2012

Link Between Cam-Type Deformities And MRI Detected Hip Damage In Asymptomatic Young Men, Potential Progression To Osteoarthritis Of The Hip

Main Category: Arthritis / Rheumatology
Also Included In: Men’s health;  MRI / PET / Ultrasound
Article Date: 10 Sep 2011 – 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated

Hip impingement (femoracetabular impingement) may be a risk factor of osteoarthritis (OA) of the hip. A new study reveals that the presence of an underlying deformity, known as cam impingement, is associated with hip damage in young men without any arthritis symptoms and detected using magnetic resonance imaging (MRI). Full findings are now published in Arthritis Rheumatism, a journal of the American College of Rheumatology (ACR).

Medical evidence reports that hip OA is a major cause of pain and disability, and accounts for more than 200,000 hip replacements in the U.S. each year. Cam impingement limits full range of motion in the hip socket due to boney bumps on the femoral head. The cam-type deformity causes hip pain as the bump moves inside the socket, applying extreme pressure to cartilage and may eventually lead to OA in the hip. Studies have shown that cam impingement is often seen in young male athletes referred to orthopedic specialists after experiencing groin pain, and hip rotation is found to be diminished.

“Given that cam-type deformities are common in young asymptomatic males, we examined whether the deformities were associated with early signs of MRI detected hip damage,” explains lead author Dr. Stephan Reichenbach from the Institute of Social and Preventive Medicine at the University of Bern in Switzerland. The researchers recruited participants from a population-based group of male individuals enrolling in the Swiss army at a single recruiting center. A total of 244 males with a mean age of 20 years reported having no hip pain and were qualified for the study. MRIs were conducted and one hip in each participant was examined for cam-type deformities, labral lesions, signs of cartilage damage and impingement pits.

Researchers detected 67 definitive cam-type deformities in study participants with these men having higher body mass index and decreased internal rotation. Labral lesions were detected in 85% of participants with cam-type deformities and in only 67% of those without the deformity. Labral avulsions were found in 76% of participants with the deformity and 58% of those without. In participants with cam-type deformity versus those without, impingement pits were observed in 30% and 12%, respectively.

The authors report an adjusted prevalence of 24% for cam-type deformities in the study population along with a high frequency of signs of joint damage. The signs of joint damage found in participants could be an outcome in the sequence from normal to osteoarthritic hips, they suggest. “Our study is the first population-based MRI study to confirm the role of cam-type deformities of the hip as a potential risk factor for joint damage,” concluded Dr. Reichenbach. “Longer-term studies are needed to determine if cam-type deformity increases risk of developing hip OA.”

  • Additional
  • References
  • Citations

Article adapted by Medical News Today from original press release.

Visit our  arthritis / rheumatology section for the latest news on this subject.

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Wiley-Blackwell (2011, September 10). Link Between Cam-Type Deformities And MRI Detected Hip Damage In Asymptomatic Young Men, Potential Progression To Osteoarthritis Of The Hip. Medical News Today. Retrieved September 10, 2011 from
http://www.medicalnewstoday.com/releases/234145.php


MLA
Wiley-Blackwell. “Link Between Cam-Type Deformities And MRI Detected Hip Damage In Asymptomatic Young Men, Potential Progression To Osteoarthritis Of The Hip”. Medical News Today, September 10, 2011. Web. 10 Sep, 2011.


Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2011 All rights reserved.

Link Found Between Biological Agents For Rheumatoid Arthritis And Greater Skin Cancer Risk

Editor’s Choice
Academic Journal
Main Category: Arthritis / Rheumatology
Also Included In: Melanoma / Skin Cancer
Article Date: 09 Sep 2011 – 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated

A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

“This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma.”

Written by Petra Rattue

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Petra Rattue (2011, September 9). Link Found Between Biological Agents For Rheumatoid Arthritis And Greater Skin Cancer Risk. Medical News Today. Retrieved September 9, 2011 from
http://www.medicalnewstoday.com/articles/234187.php


MLA
Petra Rattue. “Link Found Between Biological Agents For Rheumatoid Arthritis And Greater Skin Cancer Risk”. Medical News Today, September 9, 2011. Web. 9 Sep, 2011.


Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2011 All rights reserved.

Equipping a New Hospital…Helping a Little Girl Hear (via American Medical Resources Foundation)

Equipping a New Hospital...Helping a Little Girl Hear News on Shipments There’s nothing more gratifying than to see shipments head out the door. Here’s what’s been happening this Spring. On  May 3rd we shipped a 40’ container to Dominican Republic (ADR) On May 10th we loaded a 53’ truck for a shipment that includes medical equipment and hospital supplies destined for a series of hospitals serving needy communities scattered throughout Mexico. Sponsoring these donations are the Red Internacional de A … Read More

via American Medical Resources Foundation



Eco World Content From Across The Internet.

EcoPressed
Featured on EcoPressed


Google reveals electricity use, aims for a third clean power by 2012

Advertisement

June 14, 2011

Leave a comment


Protective Protein Prevents Immune System From Ravaging Joints And Bones In Rheumatoid Arthritis

Main Category: Arthritis / Rheumatology
Article Date: 09 Sep 2011 – 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated

Researchers at Northwestern University Feinberg School of Medicine have discovered why the immune cells of people with rheumatoid arthritis become hyperactive and attack the joints and bones. The immune cells have lost their bouncer, the burly protein that keeps them in line the same way a bouncer in a nightclub controls rowdy patrons.

The Feinberg School team has identified this bouncer, a protein called P21, which prevents immune cells from launching into their destructive rampage through the cartilage and bone. When the scientists developed and injected an imitation of the protein into an animal model of rheumatoid arthritis, the disease process was halted.

“The bouncer molecule stopped the immune cells from going crazy,” said lead author Harris Perlman, associate professor of rheumatology at Northwestern’s Feinberg School. “Imagine destructive customers in a bar, and the bouncer says, ‘You are going to behave!’ That’s P21. This discovery opens up a new avenue for future therapies, which are greatly needed for rheumatoid arthritis.”

Previous research by the Feinberg team showed people with rheumatoid arthritis were low in P21, but the protein’s role was unknown. The new study, which will be published in the journal Arthritis Rheumatism, reveals the protein’s vital role in keeping the immune cells in check.

Currently, there is no effective, nontoxic way to stop the hyperactive immune cells, Perlman said.

To develop the new approach, Perlman and his team tested five different parts, called peptides, of P21. He slipped each peptide into a “ghostlike” molecule that he injected into mice with a rheumatoid arthritis-like disease. The molecule secretly infiltrated the immune cells. After the seven-day trial, one of the tested peptides had calmed the overactive immune cells without toxic effects. Next, Perlman plans a 30-day study with the same peptide to monitor efficacy and toxicity over a longer period of time.

Existing treatments for rheumatoid arthritis include low-level chemotherapy and steroids. These are not always effective, however, and they are frequently accompanied by side effects. A newer class of therapy, which is sometimes used in combination with chemotherapy and steroids, is biologic response modifiers. These are antibodies or other proteins that reduce the inflammation produced by the hyperactive immune cells. These biologics don’t work for everyone, though, and can be associated with side effects including the risk of infection.

  • Additional
  • References
  • Citations

Article adapted by Medical News Today from original press release.

Visit our  arthritis / rheumatology section for the latest news on this subject.

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Northwestern University (2011, September 9). Protective Protein Prevents Immune System From Ravaging Joints And Bones In Rheumatoid Arthritis. Medical News Today. Retrieved September 9, 2011 from
http://www.medicalnewstoday.com/releases/234078.php


MLA
Northwestern University. “Protective Protein Prevents Immune System From Ravaging Joints And Bones In Rheumatoid Arthritis”. Medical News Today, September 9, 2011. Web. 9 Sep, 2011.


Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2011 All rights reserved.

reasonable arrangement of the hospital beds

Under the limited resources of beds, reasonable arrangement of the hospital beds will be the main factors in deciding the efficiency of hospital management and patient satisfaction .

First, considering both the patient and the hospital,  to determine the the link bwtween service costs, waiting time, utilization of hospital beds, bed turnover rate and other indicators, and then find the service fees, waiting time, utilization of hospital beds, bed turnover rate and other indicators and the average wait forpatients Time.

Full Electric Ho The limited resources of beds, hospital beds and reasonable arrangement in deciding the efficiency of hospital management and patient satisfaction, the main factors.

Semi Electric Medical Beds combines automatic adjustable bed positioning of the upper body and knees with the economy of manual bed-height adjustment. Pendant control for electric bed raises and lowers the upper body and/or knees. Manual crank adjusts bed-frame height for caregiver assistance.

Manual Medical Equipments offers the same convenient features as an electric medical hospital bed model but adjusts manually for the greatest economical advantage. Manual cranks raise and lower upper body and knees as well as bed height.

The Boston range of beds can be specified in two different combinations for maximum flexibility and safety. Simply choose either a bed with four plastic feet or with castors. The Features of the hosptal bed is Excellent value, strong and durable nursing care bed, and fitted with four plastic feet or castors.

Zhangjiagang Aegean Technology Co., Ltd. in for medical equipment that integrates with research and development, manufacturing, marketing and exporting, at the same time we have professional foreign trade team.

Our products include 3 series: Hospital furniture (electric hospital bed, manual medical bed, accompany chair, transfusion chair ect.), ABS medical trolley (ABS emergency trolley, ABS anesthesia trolley, ABS medicine trolley ect. ) , Surgical Gynecology equipment(Operating table, Delivery bed ect. ).



Eco World Content From Across The Internet.

EcoPressed
Featured on EcoPressed


College Campuses Ban Bottled Water

Advertisement

How To Make Whatsapp Run On Your Phone?

Free messaging is always in line with new technologies and tools which are promising to provide you the results that you always looked for. Chatting with your friends is the need of time and when you are using the android phone, the chances of getting connected is easier but what about your iOS based devices?

There is a solution for downloading whatsapp for ipad, ios, iphone devices and you can use WhatsApp messenger as well and for that reason you may use the tool on your iOS devices as well. If you have internet on phone, then you are certainly using this app for various reasons.

Few things about whatsapp for your ios

To communicate easily with your friends, there is a whatsapp version for your iPAD as well which keep your communication supple by getting you connected with the people you love to talk. Whatsapp web version is there which promotes healthy way of communication and the latest version ensures that no security threats are observed.

Web version of this app is easy to be managed and when it comes to talking with your friends, you can be an absolute winner as this app makes communication really easier and free from any technical glitches.

How to connect through Whatsapp?

For establishing the connection, certain procedure is to be followed which requires you to scan the QR code. Scanning the code always comes out to be a major step that you need to take while using this app. You just need to log into the tool and here you are, talking with your friends in a trouble free manner.

The option to find this tool is there in the settings of whatsapp and through the menu, it becomes easier to locate this as well. While connecting your phone with the internet, Whatsapp works smoothly and with the latest version available, this connection becomes easier to be established.

How Whatsapp gets installed in your iphone?

Officially there is no version of whatsapp which is available for your iphone but alternatives are always there so you can make this app run on your phone. Check out the procedure for the same which is as follows:

  • On the ipad, open the safari and reach up for the weblink – web.whatsapp.com
  • From this link, you will be directed to the home page of WhatsApp
  • On this URL just tap and swipe it down and you get to access the top drawer where the favorite menu appears, this happens when you type the web address
  • Tap on the load desktop site option
  • Interface for WhatsApp web is displayed on the page and with the QR code available, you can reach up for settings to the WhatsApp web and by scanning the QR code two devices can be paired together
  • All the recent messages are displayed which is plausible from the voice notes that you will receive soon after this app gets installed in your phone

Despite of some limitations, there are many advantages of using the app which you can find to be quite suitable for establishing the communication link with your friends.

Chondroitin Sulfate Improves Hand Function, Relieves Morning Stiffness Caused By Osteoarthritis

Main Category: Arthritis / Rheumatology
Article Date: 07 Sep 2011 – 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated

New research shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with osteoarthritis (OA) of the hand compared with those in the placebo group. Results of the clinical trial available in Arthritis Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), also report that chondroitin sulfate improves grip strength and relieves morning stiffness.

The ACR estimates that OA – the most common form of arthritis – affects more than 27 million adults in the U.S., causing joint pain and stiffness. Approximately 10% of the world population, 60 years and older, have symptomatic osteoarthritis according to the Global Burden of Disease 2000 report from the World Health Organization (WHO). Prior studies have found that 20% to 30% of adults have OA of the hand, with the prevalence rising to more than 50% after 60 years of age.

“Although hand OA is highly prevalent among adults and can significantly impact the quality of life for suffers, therapeutic options are still limited,” said Cem Gabay, M.D., with University Hospitals of Geneva in Switzerland and lead investigation of the Finger osteoArthritis Chondroitin Treatment Study (FACTS). “There are few trials examining therapeutic approaches specific to hand OA and much of the available evidence has been extrapolated from studies investigating other forms of OA.”

The single-center, placebo-controlled FACTS trial included 162 patients with radiographic hand OA who met inclusion criteria – spontaneous hand pain on the visual analogue scale (VAS) of 40 mm (scale 0-100) or more and Functional Index for Hand OA (FIHOA) level of 6 (scale 0-30). Participants received either 800 mg of chondroitin sulfate (80 patients) or placebo (82 patients) once daily for 6 months.

Results showed that patients in the chondroitin sulfate group had significant decrease in global hand pain compared with the placebo group, reflecting an 8.7 decrease on the VAS. Hand function also improved significantly for those taking chondroitin sulfate, decreasing more than 2 points on the FIHOA. Researchers also reported significantly improved hand function and reduction in morning stiffness for participants taking chondroitin sulfate versus placebo.

“Our findings show chondroitin sulfate is a safe and effective treatment for patients with hand OA,” concluded Dr. Gabay. “Alternative therapies, such as nonsteroidal anti-inflammatory drugs (NSAIDs), provide similar pain reducing effects, but with considerably more long-term toxicities.” Chondroitin sulfate is a naturally occurring molecule and a main component of joint cartilage. The chondroitin sulfate agent used in this study (Chondrosulf®) is licensed as a drug in Europe and not as a nutripharmaceutical; in the U.S. chondroitin sulfate is sold as a supplement and often paired with glucosamine.

  • Additional
  • References
  • Citations

Article adapted by Medical News Today from original press release.

Visit our  arthritis / rheumatology section for the latest news on this subject.

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Wiley-Blackwell (2011, September 7). Chondroitin Sulfate Improves Hand Function, Relieves Morning Stiffness Caused By Osteoarthritis. Medical News Today. Retrieved September 7, 2011 from
http://www.medicalnewstoday.com/releases/233913.php


MLA
Wiley-Blackwell. “Chondroitin Sulfate Improves Hand Function, Relieves Morning Stiffness Caused By Osteoarthritis”. Medical News Today, September 7, 2011. Web. 7 Sep, 2011.


Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2011 All rights reserved.

Chondroitin Sulphate Effective Treatment For Patients With Osteoarthritis

Editor’s Choice
Academic Journal
Main Category: Arthritis / Rheumatology
Article Date: 06 Sep 2011 – 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated

Chondroitin sulfate has been revealed in a new investigation to considerably reduce pain, improve hand function, enhance grip strength and relieve morning stiffness for individuals with osteoarthritis (OA) of the hand, in comparison with patients in the placebo group. Results of the study are available in Arthritis Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).

In the U.S., osteoarthritis, the most common form of arthritis, is estimated by the ACR to affect over 27 million adults. According to the Global Burden of Disease 2000 study from the World Health Organization (WHO), around 10% of the world population 60 years and over have OA. Previous investigations have discovered that OA of the hand affects 20% to 30% of adults. After 60 years of age, the incidence rose to over 50%.

Cem Gabay, M.D., with University Hospitals of Geneva in Switzerland and lead investigation of the Finger osteoArthritis Chondroitin Treatment Study (FACTS), explained:

“Although hand OA is highly prevalent among adults and can significantly impact the quality of life for suffers, therapeutic options are still limited.
There are few trials examining therapeutic approaches specific to hand OA and much of the available evidence has been extrapolated from studies investigating other forms of OA.”

162 patients with radiographic hand osteoarthritis were included in the single-center, placebo-controlled FACTS trial, all of whom met inclusion criteria, spontaneous hand pain on the visual analogue scale (VAS) of 40 mm (scale 0-100) or more and Functional Index for Hand OA (FIHOA) level of 6 (scale 0-30). The participants were divided into two groups, 80 patients received 800 mg of chondroitin sulfate, and 82 patients received a placebo once daily over a 6 month period.

Results revealed that in the chondroitin sulfate group, patients had a considerable reduction in global hand pain in comparison to the other group, displaying a decrease of 8.7 on the VAS. Chondroitin sulfate was also shown to substantially improve hand function, reflecting a decrease of over 2 points on the FIHOA, and reduce morning stiffness compared to the placebo group.

Dr. Gabay concluded:

“Our findings show chondroitin sulfate is a safe and effective treatment for patients with hand OA. Alternative therapies, such as nonsteroidal anti-inflammatory drugs (NSAIDs), provide similar pain reducing effects, but with considerably more long-term toxicities.”

A naturally occurring molecule and a main component of joint cartilage, the chondroitin sulfate agent used in this investigation (Chondrosulf®) is licensed as a drug in Europe and not as a nutripharmaceutical; Chondroitin sulfate is sold in the United States as a supplement and usually paired with glucosamine.

Written by Grace Rattue

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Grace Rattue (2011, September 6). Chondroitin Sulphate Effective Treatment For Patients With Osteoarthritis. Medical News Today. Retrieved September 6, 2011 from
http://www.medicalnewstoday.com/articles/233932.php


MLA
Grace Rattue. “Chondroitin Sulphate Effective Treatment For Patients With Osteoarthritis”. Medical News Today, September 6, 2011. Web. 6 Sep, 2011.


Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2011 All rights reserved.